Steve Valiquette
Stock Analyst at Barclays
(1.53)
# 3,402
Out of 5,182 analysts
147
Total ratings
48.08%
Success rate
-1.59%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $8 → $9.5 | $13.95 | -31.90% | 6 | Nov 10, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $5.85 | +105.13% | 13 | Oct 31, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $828.32 | -25.63% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $2.28 | +294.74% | 7 | Mar 1, 2024 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $18.38 | +30.58% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $78.36 | +9.75% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $43.50 | +95.40% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $445.77 | -32.70% | 4 | Jun 28, 2023 | |
| LTC LTC Properties | Maintains: Underweight | $35 → $34 | $38.41 | -11.48% | 3 | May 3, 2023 | |
| THC Tenet Healthcare | Maintains: Overweight | $70 → $105 | $185.53 | -43.41% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $84.70 | -35.06% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $20.29 | -35.91% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $179.51 | -20.90% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $36.40 | -86.26% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $100.92 | -43.52% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $210.00 | -60.95% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $16.20 | +11.11% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $46.67 | -33.58% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $179.22 | +109.24% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $38.76 | -50.98% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $223.62 | +154.90% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $202.34 | -68.37% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $282.58 | +9.70% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $354.69 | +59.29% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $1.17 | +6,310.26% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $8.10 | +134.57% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $2.81 | +255.87% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $6.75 | +196.30% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $76.19 | +241.25% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8 → $9.5
Current: $13.95
Upside: -31.90%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $5.85
Upside: +105.13%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $828.32
Upside: -25.63%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $2.28
Upside: +294.74%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $18.38
Upside: +30.58%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $78.36
Upside: +9.75%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $43.50
Upside: +95.40%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $445.77
Upside: -32.70%
LTC Properties
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $38.41
Upside: -11.48%
Tenet Healthcare
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $185.53
Upside: -43.41%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $84.70
Upside: -35.06%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $20.29
Upside: -35.91%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $179.51
Upside: -20.90%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $36.40
Upside: -86.26%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $100.92
Upside: -43.52%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $210.00
Upside: -60.95%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $16.20
Upside: +11.11%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $46.67
Upside: -33.58%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $179.22
Upside: +109.24%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $38.76
Upside: -50.98%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $223.62
Upside: +154.90%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $202.34
Upside: -68.37%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $282.58
Upside: +9.70%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $354.69
Upside: +59.29%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $1.17
Upside: +6,310.26%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $8.10
Upside: +134.57%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $2.81
Upside: +255.87%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $6.75
Upside: +196.30%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $76.19
Upside: +241.25%